As a result, the abnormal activation of BTK can lead to several B-cell malignancies, including various types of leukemias and lymphomas (16), as well as autoimmune disorders such as rheumatoid arthritis (RA) and multiple sclerosis (MS) (17). The gene discussed is BTK; the disease is lymphoma.